Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $58.00 Price Target at Jefferies Financial Group
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its target price hoisted by Jefferies Financial Group from $54.00 to $58.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 24.81% from the stock’s previous close. Several […]
Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its target price hoisted by Jefferies Financial Group from $54.00 to $58.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 24.81% from the stock’s previous close. Several […]
